Original Article. Gentamicin-Induced Nephrotoxicity in Adult Sheep

Similar documents
Protein Synthesis Inhibitors

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

Health Products Regulatory Authority

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Patients. Excludes paediatrics, neonates.

Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Introduction to Pharmacokinetics and Pharmacodynamics

Persistent in Kidneys

ONCE DAILY GENTAMICIN DOSING AND MONITORING IN ADULTS POLICY QUESTIONS AND ANSWERS

SUMMARY OF PRODUCT CHARACTERISTICS. KELAPRIL 2.5 mg, film coated tablets for dogs and cats [FR] KELAPRIL 2,5 film coated tablets for dogs and cats

Cell Wall Inhibitors. Assistant Professor Naza M. Ali. Lec 3 7 Nov 2017

Ylva Sjöström 1) and Anna Lennquist 2)

Australian and New Zealand College of Veterinary Scientists. Membership Examination. Veterinary Anaesthesia and Critical Care Paper 1

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

IJBCP International Journal of Basic & Clinical Pharmacology

Dose-Dependent Amelioration of Gentamicin-Induced Nephrotoxicity in Adult Swiss Albino Rats by Vitamin B-complex - A Preliminary Study

Original Article Levofloxacin and Gentamicin Induced Nephrotoxicity Pak Armed Forces Med J 2015; 65(4): ORIGINAL ARTICLES

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill

Metacam 1.5 mg/ml oral suspension for dogs

Irish Medicines Board

Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and

My cat has kidney problems and food hypersensitivity what do I do now?

Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani

Assessment of gentamiciminduced nephrotoxicity in rats treated with low doses of ibuprofen and diclofenac sodium

Other Beta - lactam Antibiotics

European Public MRL assessment report (EPMAR)

Summary of Product Characteristics

GENTAMICIN: ACTIVITY IN VITRO AGAINST GRAMNEGATIVE ORGANISMS AND CLINICAL EXPERIENCES IN THE TREATMENT OF URINARY TRACT INFECTIONS

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension.

MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Acute Hemorrhagic Diarrhea Syndrome (AHDS) A Cause of Bloody Feces in Dogs

SUMMARY OF PRODUCT CHARACTERISTICS

1 TRADE NAME OF THE MEDICINAL PRODUCT. Gentamicin Paediatric 20mg/2ml Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Fortekor 5 mg. Tablets for Dogs and Cats

SELECT NEWS. Florfenicol Monograph: Injectable & Oral Therapy for Swine

Pharmacological Evaluation of Amikacin in Neonates

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

FICUS CARICA L. (ANJIR) LEAF EXTRACT EFFECTS ON NEPHROTOXIC CHANGES IN GENTAMICIN TREATED ALBINO MICE

BOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Hymatil 300 mg/ml solution for injection for cattle and sheep Tilmicosin

Part II SUMMARY OF PRODUCT CHARACTERISTICS. Each tablet contains 25 mg Clindamycin (as Clindamycin Hydrochloride)

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

Summary of Product Characteristics

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT FAULKNER STATE COMMUNITY COLLEGE

PCR detection of Leptospira in. stray cat and

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

SUMMARY OF PRODUCT CHARACTERISTICS

Comparative Low-Dose Nephrotoxicities of Gentamicin, Tobramycin, and Amikacin

Comparison of the Nephrotoxicity of Netilmicin and

folate-derived cofactors purines pyrimidines Sulfonamides sulfa drugs Trimethoprim infecting bacterium to perform DNA synthesis cotrimoxazole

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

SELECT NEWS. Florfenicol Monograph: Injectable Therapy for Cattle

Summary of Product Characteristics

RENAL CLEARANCE OF CARPROFEN IN THE ISOLATED PERFUSED RAT KIDNEY

Summary of Product Characteristics

Pharmacology Week 6 ANTIMICROBIAL AGENTS

Irish Medicines Board

Principles of Antimicrobial therapy

SUMMARY OF PRODUCT CHARACTERISTICS. Procaine penicillin Dihydrostreptomycin Sulfate

SUMMARY OF PRODUCT CHARACTERISTICS. Enrotron 50 mg/ml Solution for injection for cattle, pigs, dogs and cats

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

FLOXYME 50 mg/ml SOLUTION FOR USE IN DRINKING WATER

Copper-Storage Liver Disease Basics

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1

- Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.

1. NAME OF THE VETERINARY MEDICINAL PRODUCT

Gentamicin, Netilmicin, Dibekacin, and Amikacin Nephrotoxicity and Its Relationship to Tubular Reabsorption in Rabbits

Curricular Components for Infectious Diseases EPA

Enteric Clostridia 10/27/2011. C. perfringens: general. C. perfringens: Types & toxins. C. perfringens: Types & toxins

PHARMACOKINETICS OF AMIKACIN AFTER A SINGLE INTRAVENOUS DOSE AND RESULTANT CONCENTRATIONS IN BODY FLUIDS OF THE HORSE

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses

SUMMARY OF PRODUCT CHARACTERISTICS

UPDATES ON ANTIBIOTIC THERAPY. Jennifer L. Davis, DVM, PhD, DACVIM (LA), DACVCP VA-MD College of Veterinary Medicine VA Tech, Blacksburg, VA

Aspects of the Chronic Toxicity of Gentamicin Sulfate in Cats

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Jeff Baier MS DVM Birds of Prey Foundation Broomfield, CO

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

SUMMARY OF PRODUCT CHARACTERISTICS

A Cat is Not a Dog: Specific Therapeutic Considerations World Small Animal Veterinary Association World Congress Proceedings, 2007

SUMMARY OF PRODUCT CHARACTERISTICS

4.11 Major diseases in sheep

Research update - medicines for koalas

[Version 8.1,01/2017] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Animeloxan 1.5 mg/ml oral suspension for dogs. Active substance: Meloxicam 1.5 mg (equivalent to 0.

Doxivex, 100 mg/ml concentrate for oral solution for chickens and pigs

Proceedings of the 13th International Congress of the World Equine Veterinary Association WEVA

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

SUMMARY OF PRODUCT CHARACTERISTICS

Christie Ward - The Question of Cushings

SUMMARY OF PRODUCT CHARACTERISTICS

EXCEDE Sterile Suspension

Appropriate Antimicrobial Therapy for Treatment of

SUMMARY OF PRODUCT CHARACTERISTICS

Anesthesia Check-off Form

SUMMARY OF PRODUCT CHARACTERISTICS

Transcription:

Advances in Bioresearch Volume 3 [4] December 2012: 116-120 2012 Society of Education, India [ISO 9001: 2008 Certified Organization] Website: http://www.soeagra.com/abr/abr.htm Original Article A B R ISSN 0976-4585 Gentamicin-Induced Nephrotoxicity in Adult Sheep Majid Fartashvand *, Ghafour Mousavi, Yaghoub Hajisadeghi Department of Clinical Sciences, Faculty of Veterinary Medicine, Tabriz Branch, Islamic Azad University, Tabriz, Iran ABSTRACT Gentamicin (GM) is an aminoglycoside antibiotic that is very effective in treating life-threatening gram-negative infections. Its use is, however, restricted because of several problems such as development of ototoxicity and nephrotoxicity. The GMnephrotoxicity involves renal free radical generation, reduction in antioxidant defense mechanisms, acute tubular necrosis and glomerular congestion, resulting in diminished glomerular filtration rate and renal dysfunction. The objective of this study was to monitor the nephrotoxic effects of intravenous injection of gentamicin in adult male sheep, and to identify the earliest signs of toxicity and the extent of clinical and biochemical changes. To this aim 12 clinically healthy, yearling male Iranian fat-tailed sheep injected with gentamicin sulfate at a dose rate of 80 mg/kg per day. Regularly blood samples were collected weekly before and after induction of nephrotoxicosis, throughout the study. GM-induced nephrotoxicity was characterized by an increase in serum creatinine and urea, electrolyte imbalances and incidences of albuminuria and renal dysfunction. Elevation in respiratory and heart rates were significantly increased one week after treatment (p<0.05).there were noticeable increased in thirst and water consumption, lethargy and loss of appetite in treated sheep. There were significant correlations between serum creatinine with potassium (P=0.004, r=0.759), sodium (P=0.017, r=0.501) and urea (P=0.021, r=0.617)levels.additionally, there were significant negative correlations between serum total protein and albumin with creatinine (P=0.023, r=-0.484) and urea (P=0.036, r=-0.381). At necropsy kidneys were pale and swollen and wet on the cut surface and edema, especially of perirenal tissues and ureters were apparent. These findings werecorroborated the previous reports in other species. Key words: Experimental Chronic Renal Failure, Nephrectomy, Sheep, Uremia INTRODUCTION Aminoglycosides are employed in the treatment of bacterial infections. Gentamicin (GM), an aminoglycoside class of bactericidal antibiotic, was first isolated from Micromonosporapurpurea, gram-positive bacteria widely present in water and soil, is effective against gram-negative bacterial infections and is particularly valuable in severe sepsis[3,16]. Gentamicin inhibits bacterial protein synthesis by binding to 30S ribosomal subunit and preventing the formation of initiation complex with mrna and also inducing the event of misreading of the mrna message, leading to the production of defective proteins that afford bactericidal action [3]. Gentamicin is not intended to be used orally since it is not absorbed to any appreciable extent from the small intestine. It is administered intravenously, intramuscularly or topically to treat bacterial infections. It is completely eliminated as unchanged form by glomerular filtration via urine [21].However, nephrotoxicity is a major side effect of gentamicin that restricts its clinical application [7,15], so that 30% of patients treated with GM for more than 7 d show some signs of nephrotoxicity[18].renal toxicity of gentamicin is linked to its selective accumulation in the renal cortex especiallyin proximal tubule cells[12,16]. Morphologic lesions of proximal tubules have been documented in optic microscopy [16]. Renal injury progresses slowly and its various stages can be closely followed [7].Various experimental models including rat [4,8,13,17], dog [20], lamb[7] and horse [12] are employed to induce nephropathy in order to identify the potential pharmacological targets for nephropathy. It has also been administered to ewes to produce aminoglycoside nephrotoxicosis (AGNT) as a model of acute renal failure [10, 11]. The objective of this study was to monitor the nephrotoxic effects of gentamicin in adult male sheep, and to identify the earliest signs of toxicity and the extent of clinical and biochemical changes. ~ 116 ~

MATERIALS AND METHODS Experimental animals Twelve clinically healthy, yearling male Iranian fat-tailed sheep and weighing 45-50 kg were used. All animals were kept indoor in group box during the whole experimental period, under similar conditions and manual feed including alfalfa, barley, treated wheat straw (treated with 5% urea, 2.5% molasses and 2% salt) with free access to waterfor several weeks before the trial. After deworming of sheep with Albendazol 5% (Dieverm, 15 mg/kg, PO, Damloran Razakpharma, Lorestan, Iran) and Ivermectin 1% (Intermectin, Interchemie, Holland, 200 µg/kg,sc) animal were prepared for experiment. Investigations using experimental animals were conducted in accordance with the internationally accepted principles for laboratory animal use and care, and Ethics Committee of Faculty of Veterinary Medicine, Islamic Azad University approved the protocol. Induction of Nephrosis Gentamicin-induced in animals by intravenous injection of gentamicin sulphate (Gentacin 5%, Nasr,Fariman, Iran) at a dose rate of 80 mg/kg per day.gentamicin was given daily until the plasma creatinine level of each sheep increased to a minimum of 132 μmol/litre and was then discontinued, as described by Garry et al.[10]. Sampling and laboratory procedures Regularly blood samples were collected weekly before and after induction of nephrotoxicosis, throughout the study.for biochemical analysis, approximately 5 ml blood samples were collected from jugular vein into plain serum tubes. Sera were analyzed for urea, creatinine, total protein and albumin by an automatic analyzer (Alcyon TM 300, Abbott Lab., Illinois, USA), using commercial kits (Pars Azmoon Co. INC., Karadj, Iran). Also serum potassium and sodium value were quantified by Flame photometric method. Statistical analysis All statistical analyzed by Statistical Package for Social Sciences for Windows, version 17.0 (SPSS Inc.).Data normality was tested by Kolmogorov-Smirnov test. Analysis of variance (ANOVA) test was used for comparison of measured factors in various times. All values were expressed as mean and standard deviation (SD), and P<0.05 was considered as statistically significant. RESULT There were noticeable increased in thirst and water consumption in treated sheep. Lethargy and loss of appetite were recorded after fifth day. Approximately 8 10 days after gentamicin injection, food consumption was reduced to one-half to one-third of the previous rate. Respiratory and heart rateswere significantly increased one week after treatment (p<0.05). There is no significant difference in rectal temperature, until animals become recumbent. After sternal and lateral recumbency, body temperature significantly decreased (p<0.05 and p<0.01, respectively). Bottle jaw was seen in one sheep at days 30 due to hypoproteinemia. The changes in blood constituents are shown in Table 1 and Figure 1. All sheep became uremic. Ten days after treatment began, significant and progressive increase in creatinine levels were occurred (p<0.05). Changes in the mean value of serum urea, potassium, total protein and albumin were not significant at this time. There were significant correlations between serum creatinine with potassium (P=0.004, r=0.759), sodium (P=0.017, r=0.501) and urea (P=0.021, r=0.617)levels. Additionally, there were significant negative correlations between serum total protein and albumin with creatinine (P=0.023, r=-0.484) and urea (P=0.036, r=-0.381). There was no significant correlation between serum sodium levels and any of other biochemical factors. Animals died on 27 33 days after treatment began, due to renal failure. Toxic nephrosis signs were macroscopically apparent at necropsy. So that kidneys were pale and swollen and wet on the cut surface and edema, especially of perirenal tissues and ureters were apparent (Figure 2).There were hemorrhagic and gray necrotic streaks radiate out through the medulla and extend to the cortex (Figure 3). ~ 117 ~

Table 1: serum biochemical parameters in sheep with experimental renal failure (Mean±SD) Time (Days) 0 5 10 15 20 25 30 35 40 Urea(mg/dL) 50.3 ± 4 53.2 ± 6 57.0 ± 8 55.1 ± 9 79.6 ± 7 102.3 ± 4 134.3 ± 8 150.3 ± 4 202.6 ± 7 Creatinin(mg/dL) 0.23 ± 0.25 ± 1.69 ± 3.19 ± 4.89 ± 6.61 ± 7.75 ± 8.02 ± 8.14 ± 0.05 0.04 0.9 1.2 2.0 2.3 2.2 1.7 1.8 Sodium(mmol/dL) 141 ± 6 142 ± 11 140 ± 9 138 ± 18 138 ± 16 137 ± 21 136 ± 13 138 ± 12 139 ± 9 Potassium(mmol/dL) 4.07 ± 4.14 ± 4.23 ± 4.42 ± 5.65 ± 6.47 ± 7.12 ± 7.65 ± 8.89 ± 0.7 0.6 0.8 0.7 0.9 0.5 1.0 1.1 1.6 Protein(g/dL) 66.1 ± 68.22 ± 67.48 ± 66.26 ± 64.15 ± 62.81 ± 61.07 ± 60.18 ± 58.68 ± 5.3 7.9 8.1 10.2 10.6 12.8 11.3 13.4 15.0 Albumin(g/dL) 23.23 ± 24.84 ± 23.64 ± 24.49 ± 25.20 ± 24.66 ± 21.43 ± 21.73 ± 19.10 ± 4.0 3.8 4.7 4.2 3.3 3.6 4.4 7.2 8.4 Figure 1: Serum levels of creatinine (A), urea(b), potassium(c), sodium(d), total protein and albumin(e) in sheep with nephrotoxicosis ~ 118 ~

Figure 2: Pale and swollen kidneys, and edematous ureters; hemorrhagic points in bladder Figure 3: wetness of cut surface of kidney and swollen kidneys, and hemorrhagic points and gray necrotic streaks were apparent. DISCUSSION Results of this study corroborated the previous reports in other species in which gentamicin at dose of 80 mg/kg body weight significantly produced nephrotoxicity[1,5,12]. It has been reported that GM-induced nephrotoxicity is characterized by direct tubular necrosis, which is localized mainly in the proximal tubule[18].the specificity of gentamicin for renal toxicity is apparently related to its preferential accumulation in the renal proximal convoluted tubules (50 to 100 times greater than serum)[2].the exact mechanism of GM-induced nephrotoxicity is unknown. However, studies showed that primary retention of gentamicin in proximal tubular cells following production of oxygen-associated metabolites and free radicals precede gentamicin-induced nephrotoxicity [14,16,18,22].At the ultrastructural level, the earliest lesions observed concern the lysosomes, which show an accumulation of myeloid bodies[16]. This study showed that after intravenous administration of gentamicin (80 mg/kg BW) caused a significant increase in serum BUN and decreased creatinine clearance. Fukuda et al. [9]91) explicitly showed the electrolyte abnormalities upon treatment of rats with gentamicin.such immediate formation of disturbance further supports the notion in which inactivation of Na/K ATPase is a very early event during interaction of gentamicin with proximal tubular cells.it also indicates that simultaneous inhibition of very different membrane protein species is not necessarily a prerequisite for the initial depression of Na/K ATPase and afterwards, multifactorial ~ 119 ~

Fartashvand et al/ Gentamicin-Induced Nephrotoxicity in Adult Sheep cell death processes [9].Elevation of fractional excretion rates of Na, K, Cl, and P to many folds above baseline values on days 7 and 8 after gentamicin treatment has been reported [10], indicating decreased tubular reabsorption or increased tubular secretion. Nephropathy developed after administration of gentamicin (80 mg/kg, i.p.) for eight days in rats with proteinuria, increased serum creatinine and BUN, increased urinary loss of sodium and potassium, and glomerulosclerosis[13]. Remarkable observations offered in (1992) a well-define theory, in which hypocalcemia has been recognized of subsequent intracellular events between either inhibition of basolateral calcium ATPase, Na/K ATPase or blockage of intraluminal calcium channels and competition of gentamicin with calcium for binding brush border[6]. In addition to conjugated hypo-phosphatemia in gentamicin-treated rats, it was known to eliminate the problems of consequent nephrocalcinosis with the hypocalcemia [19]. ACKNOWLEDGEMENTS The authors would like to thank Tabriz Branch, Islamic Azad University for the financial support of this research, which is based on a research project contract. REFERENCES 1. Abdel-Gayoum, AA; Ali, BH; Abdel-Razig, KM; Bashir, AA and Ghywarsha, K (1994). Effect of gentamicin-induced nephrotoxicity on some carbohydrate metabolic pathways in the rat renal cortex. Arch. Toxicol., 68:643-647. 2. Abdel-Raheem, I.T., Abdel-Ghany, A.A. and Mohamed, G.A., 2009. Protective effect of quercetin against gentamicininduced nephrotoxicity in rat. Biol. Pharm. Bull. 32(1): 61-67. 3. Balakumar, P., Chakkarwar, V.A., Kumar, V., Jain, A., Reddy, J. and Singh, M., 2008. Experimental models for nephropathy. Journal of the ReninAngiotensinAldosterone System, 9(4): 189-195 4. Barr, G.A., Mazze, R.I., Cousins M.J. and Kosek, J.C. 1973. An animal model for combined methoxyflurane and gentamicin nephrotoxicity. Br. J. Anaesth., 45(4): 306-312. 5. Elfarra, AA; Duescher, RJ; Sausen, PJ; O'Hara, TM and Cooley, AJ (1994). Methimazole protection of rats against gentamicin-induced nephrotoxicity. Can. J. Physiol Pharmacol., 72: 1238-1244 6. Elliott, WC and Patchin, DS (1992). Aminoglycoside-mediated calciuresis. J. Pharmacol. Exp. Ther., 262: 151-156. 7. Fadel, A.A. and Larking, H.A., 1996. Gentamicin-induced nephrotoxicosis in lambs. Research in Veterinary Science, 61: 187-192 8. Frazier DL, Aucoin DP, RiviereJE., (1988). Gentamicin pharmacokinetics and nephrotoxicity in naturally acquired and experimentally induced disease in dogs. J Am Vet Med Assoc., 192(1):57-63. 9. Fukuda, Y; Malmborg, AS and Aperia, A (1991). Gentamicin inhibition of Na, KATPase in rat kidney cells. Acta Physiol. Scand., 141: 27-34. 10. Garry F, Chew DJ, HoffsisGF., (1990a). Enzymuria as an index of renal damage in sheep with induced aminoglycoside nephrotoxicosis. Am J Vet Res., 51(3):428-32. 11. Garry F, Chew DJ, HoffsisGF., (1990b). Urinary indices of renal function in sheep with induced aminoglycoside nephrotoxicosis. Am J Vet Res., 51(3):420-7. 12. Harst, M.R., Bull, S., Laffont, C.M. and Klein, W.R., (2005). Gentamicin nephrotoxicity- a comparition of in vitro findings with in vivo experiments in equines. Vet Res Commun, 29: 247-261 13. Kumar VK, Naidu MUR, Shifow A, Ratnakar KS. (2000).Probucol protects against gentamicin-induced nephrotoxicity in rats. Indian J Pharmacol;32:108-13 14. Luft, F.C. and Kleit, S.A., (1974).Renal parenchymal accumulation of aminoglycoside antibiotics in rats. J Infect Dis, 130:65 15. Martínez-Salgado, C., López-Hernández, F.J., López-Novoa, J.M., (2007). Glomerular nephrotoxicity of aminoglycosides. Toxicology and Applied Pharmacology 223: 86 98 16. Morin, J.P., Viotte, G., Vandewalle, A., Van Hoof, F., Tulkens, P. and Fillastre, J.P., (1980). Gentamicin-induced nephrotoxicity: A cell biology approach. Kidney International, 18: 583-590 17. Obatomi, D.K. and Plummer, D.T., 1995. Renal damage caused by gentamicin: a study of the effect in vitro using isolated rat proximal tubular fragments. Toxicology Letters, 75: 75-83 18. Pedraza-Chaverrí J, González-Orozco AE, Maldonado PD, Barrera D, Medina-Campos ON, Hernández-Pando R., (2003). Diallyl disulfide ameliorates gentamicin-induced oxidative stress and nephropathy in rats. Eur J Pharmacol., 473(1):71-8. 19. Reeves, PG; Rossow, KL and Lindlauf, J (1993). Development and testing of the AIN-93 purified diets for rodents: results on growth, kidney calcification and bone mineralization in rats and mice. J. Nutr., 123: 1923-1931. 20. Spangler WL, Adelman RD, Conzelman GM Jr, Ishizaki G., (1980). Gentamicin nephrotoxicity in the dog: sequential light and electron microscopy. Vet Pathol., 17(2):206-17. 21. Weismann D, Herrig J, McWeeny O., (1982). Tissue distribution of gentamicin in lambs: effect of postnatal age and acute hypoxemia. DevPharmacolTher., 5(3-4):194 206. 22. Yanagida, C., Ito, K., Komiya, I., Horie, T., (2004). Protective effect of fosfomycin on gentamicin-induced lipid peroxidation of rat renal tissue. Chemico-Biological Interactions, 148(3): 139 147. [Received 25.10.12; Accepted: 21.11.12] ~ 120 ~